Simplex Trading’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,600
Closed -$1K 9934
2024
Q2
$1K Sell
1,600
-431,100
-100% -$1.08M ﹤0.01% 8626
2024
Q1
$3.91M Buy
432,700
+431,600
+39,236% +$4.2M ﹤0.01% 1792
2023
Q4
$11K Sell
1,100
-6,000
-85% -$45K ﹤0.01% 7395
2023
Q3
$57K Sell
7,100
-4,600
-39% -$38.3K ﹤0.01% 5691
2023
Q2
$127K Buy
11,700
+2,000
+21% +$17.1K ﹤0.01% 4797
2023
Q1
$66K Sell
9,700
-13,200
-58% -$82.8K ﹤0.01% 5620
2022
Q4
$91K Buy
22,900
+10,400
+83% +$51.1K ﹤0.01% 5199
2022
Q3
$83K Buy
12,500
+9,500
+317% +$58.5K ﹤0.01% 5780
2022
Q2
$14K Sell
3,000
-100
-3% -$608 ﹤0.01% 7999
2022
Q1
$28K Buy
3,100
+400
+15% +$3.97K ﹤0.01% 7875
2021
Q4
$32K Sell
2,700
-11,300
-81% -$131K ﹤0.01% 7830
2021
Q3
$261K Hold
14,000
﹤0.01% 5146
2021
Q2
$251K Buy
14,000
+13,935
+21,438% +$224K ﹤0.01% 5303
2021
Q1
$100K Buy
+65
New +$940 ﹤0.01% 5756
2020
Q4
Sell
-730
Closed -$937K 9259
2020
Q3
$937K Buy
730
+711
+3,742% +$6.14K ﹤0.01% 2299
2020
Q2
$19K Sell
19
-27
-59% -$248 ﹤0.01% 6273
2020
Q1
$37K Buy
46
+16
+53% +$139 ﹤0.01% 5451
2019
Q4
$25K Buy
30
+16
+114% +$90 ﹤0.01% 5798
2019
Q3
$8K Sell
14
-296
-95% -$2.39K ﹤0.01% 6397
2019
Q2
$514K Sell
310
-301
-49% -$5.23K ﹤0.01% 2537
2019
Q1
$1.02M Buy
611
+319
+109% +$4.59K ﹤0.01% 1984
2018
Q4
$335K Buy
292
+268
+1,117% +$5.42K ﹤0.01% 2611
2018
Q3
$97K Sell
24
-44
-65% -$1.25K ﹤0.01% 4465
2018
Q2
$190K Sell
68
-80
-54% -$1.77K ﹤0.01% 3547
2018
Q1
$70K Buy
148
+144
+3,600% +$3.43K ﹤0.01% 2101
2017
Q4
$1K Buy
+4
New +$108 ﹤0.01% 5696

Simplex Trading's MRNS Position: Q1 2025 in Review

Simplex Trading sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 9,526 shares — an estimated $5K sold.

Simplex Trading first reported a position in MRNS in Q3 2017 and held it in 26 quarters. The position peaked at $1.06M in Q1 2019. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

  • Simplex Trading reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 9,526 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $5K.
  • Simplex Trading first reported a position in Marinus Pharmaceuticals, Inc in Q3 2017 and held it in 26 quarters.
  • Simplex Trading's Marinus Pharmaceuticals, Inc position peaked at $1.06M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.